Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
An announcement from MicroPort Scientific ( (HK:0853) ) is now available.
MicroPort Scientific Corporation has announced a non-binding proposal for the strategic restructuring of its cardiac rhythm management (CRM) business. The proposal aims to consolidate the CRM business with MicroPort CardioFlow Medtech Corporation to enhance resource integration, competitiveness, and long-term value creation. This restructuring is expected to impact the company’s operations by fostering collaboration between different business segments, although it remains subject to further negotiations, definitive agreements, and necessary approvals.
The most recent analyst rating on (HK:0853) stock is a Hold with a HK$7.30 price target. To see the full list of analyst forecasts on MicroPort Scientific stock, see the HK:0853 Stock Forecast page.
More about MicroPort Scientific
MicroPort Scientific Corporation is a leading medical device group incorporated in the Cayman Islands, with shares listed on the main board of The Stock Exchange of Hong Kong Limited. The company focuses on innovating, manufacturing, and marketing high-end medical devices globally across various segments, including cardiovascular, orthopedics, cardiac rhythm management (CRM), endovascular and peripheral vascular, neurovascular, structural heart disease, and surgical robots.
Average Trading Volume: 20,251,408
Technical Sentiment Signal: Buy
Current Market Cap: HK$16.17B
See more insights into 0853 stock on TipRanks’ Stock Analysis page.